Detalhe da pesquisa
1.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Lancet Oncol
; 21(10): 1296-1308, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919527
2.
Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.
Br J Cancer
; 120(2): 247-255, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563991
3.
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.
Cancers (Basel)
; 15(9)2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174056
4.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Nat Commun
; 11(1): 2662, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471999
5.
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.
Clin Cancer Res
; 23(18): 5561-5572, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28606920
6.
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.
Clin Cancer Res
; 23(21): 6708-6720, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765325
7.
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.
Cancer Discov
; 6(8): 838-851, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179038